Blood Coagulation Disorder Clinical Trial
Official title:
The Fear F8ctor Study - Does Fear Induce a Blood Curdling State? The Origin Behind the Phrase Unravelled
For centuries the term "blood curling" has been used to describe extreme frightening
situations. However, the origin of this ancient theory has never been studied and it remains
unknown if fear induces the coagulation system.The objective was to explore the effects of
acute fear on the coagulation system while sitting still. In a crossover study design
healthy subjects will be exposed to a horrifying e.g. scary movie followed by a dull e.g.
flat movie which is shown at least 1 week after the first movie on the same day of the week
at the same time of the day. Participants will be recruited among students from the Leiden
University Medical Center. Blood will be drawn from the cubital vein 10 minutes before the
first movie, directly after the first movie. The same will be done 10 minutes before and
directly after the second movie. Blood is drawn by using a needle puncture.
Individual markers of coagulation activity will be determined from the blood samples. Pulse
rates will be measured and an anxiety/fear score will be collected from each student for
both movies.
Rationale: For centuries the term "blood curling" has been used to describe extreme
frightening situations. The term dates back to the medieval physiology, it was believed that
the human body contained four chief fluids, blood, phlegm, bile and black bile. It was
thought that fear or horror would 'run the blood cold' or 'curdle' (solidify). To date large
parts of the complex mechanism of the coagulation cascade have been unravelled and many risk
factors for clotting, i.e., thrombosis have been identified. However, the origin of this
ancient theory has never been studied and it remains unknown if fear induces the coagulation
system.
Objective: To explore the effects of acute fear on the coagulation system while sitting
still.
The investigators will compare systemic coagulation markers before and after both movies in
each subject: 13 subjects will be exposed to the horrifying movie first, followed by the
dull movie (at least 1 week later). Both movies will be shown on the same day of the week,
at the same time of the day and will last approximately 90 minutes. One group of 13 will
first view the horrifying movie, followed by the dull move the next week (Group I) and 13
subjects will be exposed to the dull movie first, followed by the horrifying movie (Group
II). Spacious seats will be used to avoid the effect of immobilisation due to tight cinema
seats. Blood is drawn at four time points (TP); (0) before the first movie (baseline), after
the first movie (1), before the second movie (2) and after the second movie (3). A needle
puncture is used to collect 12 ml of blood at each time point.
Individual markers of coagulation activity will be determined from the blood samples. Pulse
rates will be measured and an anxiety/fear score will be collected from each student for
both movies.
;
Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06174961 -
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
|
Phase 4 | |
Recruiting |
NCT04499274 -
Ondansetron and Blood Coagulation
|
N/A | |
Recruiting |
NCT04507711 -
Palonosetron and Blood Coagulation
|
N/A | |
Recruiting |
NCT06403163 -
Transfusion Surveillance in Anaesthesia
|
||
Terminated |
NCT00288808 -
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
|
Phase 1 | |
Completed |
NCT03666650 -
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
|
Phase 4 | |
Recruiting |
NCT04896203 -
Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
|
||
Completed |
NCT03821597 -
Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients
|
N/A | |
Completed |
NCT03168087 -
Plasmalyte-148 Solution and Blood Coagulation
|
||
Not yet recruiting |
NCT05698160 -
Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction
|
||
Completed |
NCT02387944 -
Bedside Evaluation of Coagulation in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT03105180 -
Irrigating Fluid and Blood Coagulation
|
N/A | |
Recruiting |
NCT03255928 -
Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
|
||
Completed |
NCT03280368 -
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
|
||
Completed |
NCT00493272 -
Dilutional Coagulopathy in Patients Undergoing Elective Surgery
|
Phase 1/Phase 2 | |
Recruiting |
NCT02720679 -
Investigation of the Genetics of Hematologic Diseases
|
||
Completed |
NCT03972839 -
Comparison of Two D-Dimers Dosing Techniques
|
||
Completed |
NCT03734588 -
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
|
Phase 1/Phase 2 | |
Completed |
NCT03876301 -
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
|
||
Completed |
NCT00001927 -
Study of Abnormal Blood Clotting in Children With Stroke
|
N/A |